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Readability of patient information and
consent documents in rheumatological
studies
Bente Hamnes1* , Yvonne van Eijk-Hustings2 and Jette Primdahl3,4,5
Abstract
Background: Before participation in medical research an informed consent must be obtained. This study
investigates whether the readability of patient information and consent documents (PICDs) corresponds to the
average educational level of participants in rheumatological studies in the Netherlands, Denmark, and Norway.
Methods: 24 PICDs from studies were collected and readability was assessed independently using the Gunning’s
Fog Index (FOG) and Simple Measure of Gobbledygook (SMOG) grading.
Results: The mean score for the FOG and SMOG grades were 14.2 (9.0–19.0) and 14.2 (12–17) respectively. The
mean FOG and SMOG grades were 12.7 and 13.3 in the Dutch studies, 15.0 and 14.9 in the Danish studies, and 14.6
and 14.3 in the Norwegian studies, respectively. Out of the 2865 participants, more than 57 % had a lower
educational level than the highest readability score calculated in the individual study.
Conclusions: As the readability level of the PICDs did not match the participants’ educational level, consent may
not have been valid, as the participants may have had a limited understanding of what they agreed to participate
in. There should be more focus on the readability of PICDs. National guidelines for how to write clear and
unambiguous PICDs in simple and easily understandable language could increase the focus on the readability of
PICD.
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Background
This study examines the readability of written patient in-
formation and consent documents (PICDs) used in
rheumatology research. Ethical guidelines for medical re-
search on human beings, which includes PICDs, were
developed by the World Medical Association in Helsinki
in 1964 [1]. The guidelines has been revised several
times, the last time in 2013 [2]. The guidelines have also
been implemented by National Ethic Committees [3–5].
Participants in medical research must give their in-
formed consent before they can participate in a study.
The consent must be free and informed, which means
that the person should not experience any kind of pres-
sure and should have the necessary information about
the research which is to be conducted. This comprises
knowledge about the purpose of the research project,
duration, methods and procedures, types of expected re-
sults, and planned dissemination. Additionally, partici-
pants should have knowledge about the study’s potential
benefits and risks, or negative consequences such as dis-
comfort. Finally, participants should also receive infor-
mation about confidentiality and data handling, in
addition to knowledge about, that they can withdraw
from the study at any time without any explanation and
without influence on their clinical care [2]. The informa-
tion should be written and easy to understand and carry
as little risk as possible of misunderstanding. In medical
research on humans, PICDs are key requirements, which
must be approved by ethical committees [3–5]. In 2012,
the European Commission described the literacy level in
the population as important. Poor literacy is a hidden
problem in most European societies, where one in five
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young people and adults lacks basic literacy skills [6].
Health literacy means the ability to read and understand
basic health information, make appropriate health deci-
sions, and take appropriate actions accordingly [7, 8].
People with poor health literacy will probably not under-
stand a PICD if the text is too complex. In addition to
the complexity of the text, participants’ reading ability is
an important factor in ensuring their understanding of
the written information. This must be taken into ac-
count when developing written materials like PICDs to
ensure that patients are provided understandable infor-
mation about the research study. This will allow them to
make an informed decision about study participation [9].
Readability describes the number of years of schooling
necessary to read and understand a text and can be mea-
sured by standardized instruments. Gunning’s Fog Index
(FOG) [10] and the Simple Measure of Gobbledygook
(SMOG) [11] are among the most commonly used in-
struments [12]. SMOG has a high correlation with FOG
(0.95–0.99) [13, 14]. Scores from the two indexes reflect
the average years of schooling a person needs to be able
to read and understand a text. A SMOG or FOG score
of 5 is equal to 5 years of schooling. In the health litera-
ture, the recommended readability level ranges from
grades 5 to 9 [15–17].
Often PICDs have higher readability level than the
study population or recommended readability level [15,
16, 18, 19]. In a study with 40 PICDs in anaesthesiology
research, the readability score for the FOG was 11.9.
This score was significantly higher than the average liter-
acy level of the Australian and New Zealand popula-
tions, where 44–46 % people have a literacy level below
the required minimum to meet the complex demands of
everyday life [16]. In a Croatian study a readability score
of 13.25 was found in informed consent documents in
diagnostic and therapeutic procedures where 80 % of the
population older than 15 years had less education [19].
Another study of patient information leaflets on physio-
therapy showed that only 11 out of 33 leaflets (33 %)
met the recommended readability level of grade 9 [15].
In addition to the readability level, the content of the
text are essential for understanding. Studies on how par-
ticipants understand medical consent documents showed
four sources of uncertainty: language, information about
risks and hazards, the nature of the procedure, and the
documents’ composition and format [20]. This is congru-
ent with the perspective of research ethical committee
members which concluded that language, structure and
format of the patient information sheet should be im-
proved [21].
A review of interventions used to improve participants’
understanding of informed consent in research showed
that one-to-one discussion and participant feedback with
a study team member improved the participant’s
understanding of the PICD. Other interventions such as
multi-media and enhanced PICDs showed mixed levels
of improvement in participant understanding [22]. Latest
reviews from 2012–14 on improving participants under-
standing of PICDs, showed that enhanced PICDs and
extended discussions were most effective [23]. For older
participants interactive multimedia and written materials
which were easy-to-read, increased the patients under-
standing of the consenting procedure [24]. For people
with low literacy the most effective strategy was talking
one-to-one with a study member, but this result is based
on a single study only [25].
In the literature, it is recommended to conduct read-
ability tests on patient materials, but this is not yet com-
mon practice [26]. During the European League Against
Rheumatism Congress in 2010 a workshop regarding
readability stressed the importance of the topic and it
was recommended to be followed up. This study aims to
document whether the readability of PICDs corresponds
with reported education or schooling level of the partici-
pants enrolled in rheumatological studies.
Methods
Materials
We identified relevant clinical studies in the rheumatol-
ogy field from each of the authors’ home countries (the
Netherlands, Denmark, and Norway). Studies were se-
lected in the researchers’ own languages to ensure that
at least one with the native language reviewed all con-
sent documents in each language.
An initial search was performed in PubMed in July
2014: #1: rheumato* OR arthritis OR arthro* OR psori-
atic OR ankylosing spondylitis OR Bechterew OR lupus
OR fibromyal* OR (inflammatory AND joint) OR
chronic widespread pain #2: (Norway OR Norwegian;
Holland OR Dutch; Denmark OR Danish) #1 AND #2.
Additionally, we used filters to identify clinical trials that
were performed within the last 10 years on humans; we
searched for trials whose full texts were available. To in-
clude enough Danish rheumatological studies, we re-
peated the search for Danish studies in Cumulative Index
to Nursing and Allied Health Literature (CINAHL).
Inclusion criteria were studies published during the
past 10 years (2004–2014), study population ≥ 18 years
of age, and a patient population with a specific rheum-
atic disease. Exclusion criteria were register-based stud-
ies, literature reviews, or other studies where no patient
information or consent forms were used, studies from
other countries than the Netherlands, Denmark, and
Norway, and studies where no information about educa-
tional level (i.e. years of education, literacy level, and
other proxies) was reported.
The titles and abstracts of the identified studies were
screened according to the admission criteria. If a study
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was not excluded based on the title or the abstract, the
full text was retrieved and assessed according to the ad-
mission criteria. All authors screened the retrieved titles,
abstracts, and full text from their own countries.
The first authors of the included studies were con-
tacted through e-mail. We contacted the authors of the
most recent studies first. They were informed about the
aims of our study and were asked whether they would
share the patient information and consent forms used in
their study. If the first author did not respond within a
week, we contacted the last author who was considered
to have overall responsibility for the study. For one
Danish and one Norwegian study, the authors were con-
tacted for information about participants’ education
level, which was not stated in the study, although the au-
thors knew it was collected [27, 28].
As we expected each author could possibly reuse parts
of the text from previous PICDs, we included only one
study from each first author unless we knew that differ-
ent people had been responsible for the development of
the PICD. When data from the same study was reported
in several papers by different first authors, only the au-
thor from the most recent paper was contacted. We
aimed to be able to retrieve patient information and
consent forms from 10 studies from each country and
included studies that fulfilled the selection criteria
consecutively.
Analysis
To assess the readability of the material, we applied the
FOG [10] and SMOG [11] to each set of PICD. FOG
grading was calculated based on a sample of approxi-
mately 100 words. The average number of words per
sentence was calculated by dividing the number of
words by the number of sentences in the sample. Words
with three or more syllables were considered hard
words. The number of hard words were counted. If poly-
syllabic words were repeated, only the first instance was
counted. Three-syllable words made up of a two-syllable
word with endings like -e, −er, −es, and -ing were omit-
ted. The summed number of words per sentence and
hard words were then multiplied with 0.4, and this gave
the final score for each sample of approximately 100
words. We used the first 100 words and last 100 words
of the text for scoring FOG 1 and FOG 2. SMOG grad-
ing was performed on 10 consecutive sentences at the
beginning, 10 in the middle, and 10 near the end of the
text. The number of words with three or more syllables
was counted (including repetitions). The square root of
the number of polysyllabic words (of the nearest perfect
square) was calculated and the number ‘3’ was added to
reach the final score [11]. In case the text did not con-
tain 30 sentences for the SMOG grading, we assessed 10
sentences from the beginning of the text, the following
10 sentences, and finally 10 sentences counted back-
wards from the end of the text. Thus, some sentences
were included twice.
In case abbreviations were defined, the abbreviated
version was not counted as a hard word no matter the
number of syllables. Headings and subheadings in the
text were calculated as sentences only in case they con-
sisted of at least two words.
Each PICD was graded independently by hand by two
of the authors. Each author scored all the PICDs from
her own country and half of the PICDs from each of the
two other countries. Next, the grades were compared. In
case of discrepancy between the calculated score, the
third author scored the material as well, and a final grad-
ing was reached by comparison and discussion.
Next, we compared the participants’ educational or
schooling level with the readability grade of the PICD
for each single study. Since the age for starting school
and the educational system varies from country to coun-
try, the years of schooling were reported based on each
country’s system (Table 1). The proportion and number
of participants with an educational or schooling level
lower than the highest score for the FOG or the SMOG
were reported.
Frequency distribution, means, and standard deviation
(SD) were calculated for the FOG and SMOG grades in
the PICDs.
Results
Through our search strategy, we retrieved 721 Dutch
studies, 256 Danish studies and 192 Norwegian studies.
After the screening, we included 24 studies, of which
seven were Dutch, seven were Danish, and ten were
Norwegian. Five of the included studies were qualitative,
and 19 were quantitative. The number of participants in
the studies ranged from 13 to 333. A total of 2972 par-
ticipants were included in the 24 studies. In 23 of these
studies, 1619 participants out of 2865 participants
(57 %) had a lower educational or schooling level than
the highest scores required for the FOG or the SMOG.
The percentage of participants with lower educational or
schooling level than the required FOG and the SMOG
scores ranged from 5 % to 84 % in the included studies
(Table 1). In one of the 24 studies, it was not possible to
calculate the proportion of participants with a lower
educational level than that suggested in the FOG/SMOG
scores, because the results were presented as mean
values [29] (Table 1).
Education or schooling levels presented in the in-
cluded studies were often graded in two or three levels.
The highest educational level was often described to be
more than 12 or 13 years of schooling or as ‘university
level’.
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Table 1 Gunning’s Fog Index (FOG) and Simple Measure of Gobbledygook (SMOG) grade levels of studies and participants’ educational levels
Study no Study design No of participants (n) Mean age and sex Participants years of schooling
or education level
FOG grade 1 FOG grade 2 SMOG grade Participants with lower
educational level than
required to understand
the PICD % (n)
The Netherlands
1 [47] Evaluation of self-
management programs
19 21 years (n = 9) and 22
years (n = 10), female 84 %
Low 1a
Middle 13b
High 5c
11.0 9.4 13 5 % (1)
2 [48] Cross-sectional study 333 47 years, female 100 % Low 15d
Middle 256e
High 62f
10.1 9.0 13 5 % (15)
3 [49] Randomised controlled
study
199 62 years, female 65 % Low 28d
Middle 79e
High 91f
Missing 1
11.7 15.5 13 54 % (107)
4 [50] Randomised controlled
study
82 48 years, female 92 % Low/intermediate 50
High 32
15.6 11.1 13 61 % (50)
5 [51] Randomised controlled
study
203 In five groups: 39 to 43
years, female 92–100 %
Low 108
Middle 68
High 27
12.3 17.6 14 87 % (176)
6 [52] Qualitative focus group
study
20 57 years, female 75 % Low 3d
Middle 12e
High 5f
13.8 11.8 12 75 % (15)
7 [53] Randomised controlled
study
158 47 years, female 94 % Primary (mean 7 years) 8
Secondary (mean 12 years) 128
Tertiary (mean 17 years) 22
15.6 13.9 15 86 % (136)
Denmark
1 [54] Randomised crossover
study
20 67 years, female 100 % Elementary school 5
High school 0
<4 years at University level 9
4–6 years at University level 2
>6 years at University level 4
16.5 12.9 14 70 % (14)
2 [55] A prospective study 315 55 years, female 77 % None 67
Vocational 102
Higher 146
18.7 16.8 16 54 % (169)
3 [56] A qualitative interview
study
16 50 years, female 75 % No formal education 2
Minimal education 7
Secondary education 4
University 3
13.0 11.0 13 69 % (9)
4 [57] A qualitative interview
study
13 44 years, male 100 % Minimal education 1
Secondary education 9
University 3
11.5 17.0 15 77 % (10)
5 [58] Randomised controlled
study
287 63 years, female 87 % <11 years 232
≥11 years 55
13.6 17.9 15 81 % (232)
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Table 1 Gunning’s Fog Index (FOG) and Simple Measure of Gobbledygook (SMOG) grade levels of studies and participants’ educational levels (Continued)
6 [59] Qualitative focus group
study
32 58 years, female 59 % Unskilled 3 Vocational 18 Undergraduate
6 Graduate 5
15.2 13.8 14 84 % (27)
7 [28] A qualitative interview
study
31 38–89 years, female 85 % <10 years 4 10–12 years 7 > 12 years 20 17.8 14.4 17 36 % (11)
Norway
1 [60] Randomised controlled
study
57 Group 1: 68 and Group 2:
69 years, female 56 %
≤12 years 24 > 12 years 33 16.9 11.4 13 42 % (24)
2 [61] Randomised controlled
study
141 58 years, female 69 % ≤12 years 88 > 12 years 53 19.0 15.1 15 63 % (88)
3 [62] Randomised controlled
study
95 49 years, female 35 % ≤12 years 58 > 12 years 37 16.6 13.8 15 61 % (58)
4 [63] Comparing treatment 153 Group 1: 57 years, female
89 %. Group 2: 51 years,
female 53 %
≤12 years 87 > 12 years 65 15.2 18.7 14 57 % (87)
5 [64] Randomised controlled
study
68 50 years, female 68 % Elementary school 13 High school 36
College/university 19
13.3 13.6 14 72 % (49)
6 [65] Randomised controlled
study
135 44 years, all female ≤10 years 21 11–13 years 49 > 13 years
53 Unknown 12
14.9 9.8 14 52 % (70)
7 [66] Follow up study 134 55 years, female 87 % 9 years 36 ≤ 12 years 43 > 12 years 55 12.8 13.3 14 59 % (79)
8 [27] A longitudinal study 281 46 years, female 58 % ≤9 years 38 10–12 years 118 > 12
years 125
12.8 13.7 15 56 % (156)
9 [29] Randomised controlled
study
107 M-group 48 years, N-group
51ys, female 43 %
Mean years of education 13 years
(M-group) 12 years (N-group)
15.0 18.7 15 Cannot be calculated
10 [67] Randomised controlled
study
73 54 years, female 79 % ≤12 years 36 > 12 years 37 12.9 13.6 14 49 % (36)
Participants in 23 studies 2865g 57 % (1619g)
Explanation of years of schooling or education level (a–f)
aVocational training
bAdvanced vocational training
cCollege/University training
dPrimary school/lower vocational secondary education
eIntermediate general secondary education/vocational education
fHigher general secondary education, higher vocational education, preuniversity or university level
gWithout the Norwegian study number 9 which cannot be calculated
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All PICDs were written in standard templates without
illustrations, figures or other initiatives that could im-
prove the readability. During the analysis, there were
minor discrepancies, which were discussed. The reasons
were often words that were overlooked, or that the pro-
nunciations were unknown for one of the authors and
thus the number of syllables could be interpreted
differently.
The total mean score for the FOG and SMOG grades
were 14.2 (9.0–19.0) and 14.2 (12–17) respectively. The
mean scores for the FOG and SMOG were 12.7 and 13.3
in the Dutch studies, 15.0 and 14.9 in the Danish stud-
ies, and 14.6 and 14.3 for the Norwegian studies, re-
spectively (Table 2).
Discussion
This study investigated whether the readability of the
PICDs corresponds with the reported education or
schooling level of the participants involved in rheumato-
logical studies in the Netherlands, Denmark, and
Norway.
The results show that in all 24 studies, the PICDs had
a higher readability level than recommended for health
literature in general [15–17], and that in all studies there
were participants with a lower educational or schooling
level than the required readability level in order to be
able to read and understand the PICD used in the study.
This corresponds with findings from a new study of 522
information sheets for research studies in the UK [30].
In total 57 % of the participants had less education or
schooling than required to read and understand the
PICD based on the readability scores for the FOG and
SMOG. When participants have a lower level of educa-
tion than the readability of the PICD, it can lead to a
‘readability gap’, meaning that participants will not fully
understand the text in the PICD or what they are agree-
ing to [31]. This may cause participants to refuse to par-
ticipate in the study or imply that they are participating
in the study without giving valid consent. Participants’
understanding of the text can be improved by oral infor-
mation or discussion with a study team member about
the content in the PICD [22]. It is also possible to in-
crease PICDs’ readability by using short words and
phrases, headings, plenty of space, bulleted lists, illustra-
tions, and large type [20, 32, 33].
An individual’s health literacy depends on more than
education; for example, it can depend on how familiar
the reader is to the health care system and the presented
information [34]. When readers possess such knowledge,
they may understand the text in PCIDs even when their
educational level is lower than the readability level of the
PICD in question. Conversely, when readers lack this
knowledge, they may fail to understand the text even
when they their educational level corresponds to the
readability level of the PCID.
The high readability level of the PICDs in this study can
possibly be explained by the regulatory requirements in
national guidelines, which give more attention to the con-
tent of the PICDs than their readability. In Denmark and
Norway, there are no stated requirements or focus on the
level of readability of the PICDs. In the Netherlands, the
ethical committees recommend to write the material on a
schooling level of lower secondary school, which is ap-
proximately at an age of 11–12 years. The literature has
shown that the readability level of PICDs in USA,
Australia, South Africa, India and several European coun-
tries does not fit requirements so it is plausible to suggest
that it is a common and worldwide problem [16, 19, 21,
35–38]. Our findings and how we have conducted our
study can therefore be relevant for health professionals
working with PICDs.
For all the included studies, we received the PICD
from the first author, and several authors commented
that the current study was an important piece of work
that they would gladly support. In this study, it was diffi-
cult to find 10 Dutch and 10 Danish studies in which
education or years of schooling was reported as part of
the participants’ demographic data. This indicate a lack
of focus on the participants’ educational of schooling
level, although social inequality is an important topic.
Patients’ educational level may affect how participants
manage their disease and treatment [39]. Educational
level can also influence the risk of disease [40], disease
severity [41], psychological distress [42], health [43], in-
volvement in healthcare [44], and mortality [45]. There-
fore, it may be advantageous for studies to report the
educational or schooling level of their participants.
This study’s strength is that it examines PICDs from
studies in three different European countries. It enables
us to obtain knowledge on the readability of PICDs in a
larger context. Using two different tests for readability
also strengthens the study. Average values for FOG and
SMOG in the PICDs are quite similar in our study, but
Table 2 Gunning’s Fog Index (FOG) and Simple Measure of
Gobbledygook (SMOG) mean scores in the PICDs in the Dutch,
Danish, and Norwegian studies
Number of values Mean (min-max) Std. Deviation
FOG-NL 14 12.7 (9.0–17.6) 2.6
FOG-DK 14 15.0 (11.0–18.7) 2.5
FOG-NO 20 14.5 (9.8–19.0) 2.4
SMOG-NL 7 13.3 (12.0–15.0) 1.0
SMOG-DK 7 14.9 (13.0–17.0) 1.4
SMOG-NO 10 14.3 (13.0–15.0) 0.7
FOG-All 48 14.2 (9.0–19.0) 2.6
SMOG-All 24 14.2 (12.0–17.0) 1.1
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within individual PICDs, there is a wide variation in
scores. This shows that the complexity of PICD texts
varies and that it is difficult to obtain a single readability
measure of the PICDs. Readability tests like FOG and
SMOG have been criticized for focusing on the docu-
ment alone, and for not capturing medical terms and
difficult words [12]. A weakness of a readability test is
that it does not take into account the context in which
the document is used [12].
For assessment of PICDs and other written patient in-
formation, there are several online tools which involve
FOG, SMOG, and other readability tests. These electronic
tools make it possible to quickly obtain the value of a
text’s readability. Online tools are not exact and provide
somewhat different results than tests scored by hand. One
such tool calculates a total readability score based on sev-
eral tests (http://www.readabilityformulas.com). Another
tool shows the readability for each test and provides a list
of which sentences should be rewritten to improve read-
ability (http://www.online-utility.org/english/readability_-
test_and_improve.jsp). This tool is used in an example of
PICD where the same text is written with high and low
readability, see Additional file 1.
In our study, several of the PICDs were only available
on paper. We also wanted to calculate the readability
level as exactly as possible. Therefore, all PICDs were
scored by hand.
Study limitation
The studies included in this study use different ways of
describing the participants’ level of education. Some use
the number of years of schooling, grouped or as average.
Other studies use low-medium-high educational classifi-
cations, and some studies describe the professions or oc-
cupations of the participants. This makes it difficult to
compare results. In most studies, there will be more par-
ticipants who have lower educational levels than PICDs’
readability level (Table 1), but the way participants’ edu-
cation is presented in the studies makes it impossible to
perform a more accurate calculation. For example, when
the number of participants in a study is presented with
an education level of more than 12 years and the highest
readability score is 19.0, then only a few in this group
will have a schooling level equivalent to 19.0 years. A
standardized way of presenting participants’ educational
level is needed.
The FOG and the SMOG were developed to score
texts written in English, which together with Dutch, Da-
nish, and Norwegian, belong to the Germanic language
family [46]. All four languages have common language
characteristics. This is why we assumed we could use
the FOG and SMOG procedure in all three languages
even though they are not yet validated in the three
languages. The endings which are considered to be easy
to understand varies between languages. We cannot ig-
nore the fact that the scores may be influenced by the
languages.
Conclusion
More than 57 % of the participants in the included stud-
ies had a lower educational or schooling level than the
readability level of the PICDs. This raises concerns about
the validity of the participants’ consent. It would be rele-
vant to develop national recommendations for the read-
ability of PICDs. In addition, the involvement of patient
research partners may help ensure a highly necessary
focus on participants’ reading level. Further research is
needed in other medical fields and in other countries.
Practice implications
Our findings show that there should be more focus on
the formulation and form of PICDs. The development of
guidelines for writing PICDs would ensure that focus is
placed on the formulation of a text that is clear and
understandable. The use of such a text along with oral
information will enable participants to understand a
study’s contents and consequences and give valid con-
sent. This will also ensure the best possible recruitment
in the studies.
Additional file
Additional file 1: PICD with high and low readability (invented).
(DOCX 15 kb)
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